BChE-IN-13
BChE-IN-13 (Compound 17c) is an orally active, potent and selective Butyrylcholinesterase (BChE) inhibitor with IC50s of 0.22 and 0.016 μM for eqBChE and hBChE, respectively. BChE-IN-13 can improve memory and cognitive impairments, and be used in Alzheimer’s disease (AD) research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2700896-73-5
- 화학식: C24H28N2O
- 분자량:360.49
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
IC50: 0.22 μM (eqBChE) 0.016 μM (hBChE)[1]
BChE-IN-13 (5-100 μM; 24 h) shows weak toxicity to SH-SY5Y, PC-12 and HT-22, and shows high mortality to BV2 cells[1].
BChE-IN-13 shows excellent blood brain barrier permeation using a parallel artificial membrane permeability assay experiment (PAMPA)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SH-SY5Y, PC12, BV2 and HT-22 cells
-
Concentration:5-100 μM
-
Incubation Time:24 hours
-
Result:Showed cells viability more than 60% of SH-SY5Y, PC-12 and HT-22 even at 100 μM. Showed high mortality in BV2 cells, and reached half the mortality at 20 μM.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice intracerebroventricularly (icv) injected with oligomerized Aβ1-42
-
Dosage:15 mg/kg
-
Administration:Oral gavage; 15 mg/kg; once daily; 6 days
-
Result:Improved the memory and cognitive function, and showed a shorter latency compared with Donepezil.
Chemical Information
-
CAS No. 2700896-73-5
-
분자량 360.49
-
화학식 C24H28N2O
-
SMILES
O=C(NC1=CC=CC=C1C)CN(CC(C)C)CC2=CC=C3C=CC=CC3=C2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)